This inventor holds 3 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Osaka University, Tao Health Life Pharma Co., Ltd.. Active years: 2013-2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2013-2016
Title: The Innovations of Shoji Ideno
Introduction
Shoji Ideno is a notable inventor based in Osaka, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of human antibodies against influenza viruses. With a total of 3 patents to his name, Ideno's work has the potential to impact public health significantly.
Latest Patents
Ideno's latest patents focus on a human anti-human influenza virus antibody. This innovative antibody exhibits neutralization activity against human influenza viruses, specifically targeting a highly conserved region in human influenza A virus subtype H3N2 and human influenza B virus. The antibody binds to the hemagglutinin HA1 region of the human influenza A virus subtype H3N2, showcasing its effectiveness in combating these viral strains. The DNA encoding the variable region of the antibody includes specific sequences set forth in SEQ ID NOS: 5 to 12, which are crucial for its functionality.
Career Highlights
Throughout his career, Shoji Ideno has been associated with prestigious institutions such as Osaka University and Tao Health Life Pharma Co., Ltd. His work in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Ideno has worked alongside notable colleagues, including Kazuyoshi Ikuta and Ritsuko Koketsu. Their combined expertise has fostered an environment of innovation and advancement in the field of biotechnology.
Conclusion
Shoji Ideno's contributions to the development of human antibodies against influenza viruses highlight his role as a significant inventor in the biotechnology sector. His work not only advances scientific knowledge but also holds promise for improving public health outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile